Biphasic activation of extracellular signal-regulated kinase (ERK) 1/2 in epidermal growth factor (EGF)-stimulated SW480 colorectal cancer cells |
Joo, Donghyun
(Department of Agricultural Biotechnology and Center for Agricultural Biomaterials)
Woo, Jong Soo (Department of Agricultural Biotechnology and Center for Agricultural Biomaterials) Cho, Kwang-Hyun (Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST)) Han, Seung Hyun (Department of Oral Microbiology and Immunology, Dental Research Institute, and BK21 Program, School of Dentistry, Seoul National University) Min, Tae Sun (National Research Foundation of Korea) Yang, Deok-Chun (Korean Ginseng Center and Ginseng Genetic Resource Bank, Kyung Hee University) Yun, Cheol-Heui (Department of Agricultural Biotechnology and Center for Agricultural Biomaterials) |
1 | Yang SH, Sharrocks AD and Whitmarsh AJ (2003) Transcriptional regulation by the MAP kinase signaling cascades. Gene 320, 3-21 DOI |
2 | Chuderland D, Konson A and Seger R (2008) Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 31, 850-861 DOI |
3 | Zeldich E, Koren R, Nemcovsky C and Weinreb M (2007) Enamel matrix derivative stimulates human gingival fibroblast proliferation via ERK. J Dent Res 86, 41-46 DOI |
4 | Huang Z, Cheng SL and Slatopolsky E (2001) Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem 276, 21351-21358 DOI |
5 | Nakayama K, Satoh T, Igari A, Kageyama R and Nishida E (2008) FGF induces oscillations of Hes1 expression and Ras/ERK activation. Curr Biol 18, R332-334 DOI |
6 | Sastre AP, Grossmann S, Reusch HP and Schaefer M (2008) Requirement of an intermediate gene expression for biphasic ERK1/2 activation in thrombin-stimulated vascular smooth muscle cells. J Biol Chem 283, 25871-25878 DOI |
7 | Sancho E, Batlle E and Clevers H (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20, 695-723 DOI |
8 | Roberts PJ and Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291-3310 DOI |
9 | Lefloch R, Pouyssegur J and Lenormand P (2008) Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol Cell Biol 28, 511-527 DOI |
10 | Traverse S, Gomez N, Paterson H, Marshall C and Cohen P (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288 (Pt 2), 351-355 DOI |
11 | Sparmann A and Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447-458 DOI |
12 | Skarpen E, Flinder LI, Rosseland CM et al (2008) MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments. FASEB J 22, 466-476 DOI |
13 | Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983-8998 DOI |
14 | Murphy LO, Smith S, Chen RH, Fingar DC and Blenis J (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4, 556-564 |
15 | Jones SM and Kazlauskas A (2001) Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol 3, 165-172 DOI |
16 | Casar B, Pinto A and Crespo P (2008) Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell 31, 708-721 DOI |
17 | Cheng C, Yaffe MB and Sharp PA (2006) A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20, 1715-1720 DOI |
18 | Monick M, Staber J, Thomas K and Hunninghake G (2001) Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J Immunol 166, 2681-2687 DOI |
19 | Volmat V, Camps M, Arkinstall S, Pouyssegur J and Lenormand P (2001) The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases. J Cell Sci 114, 3433-3443 |
20 | Sorkin A and von Zastrow M (2009) Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10, 609-622 DOI |
21 | Grammer TC and Blenis J (1997) Evidence for MEKindependent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14, 1635-1642 DOI |
22 | Balciunaite E, Jones S, Toker A and Kazlauskas A (2000) PDGF initiates two distinct phases of protein kinase C activity that make unequal contributions to the G0 to S transition. Curr Biol 10, 261-267 DOI |
23 | Jones SM, Klinghoffer R, Prestwich GD, Toker A and Kazlauskas A (1999) PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr Biol 9, 512-521 DOI |
24 | Nakanishi M and Rosenberg DW (2006) Roles of cPLA2alpha and arachidonic acid in cancer. Biochim Biophys Acta 1761, 1335-1343 DOI |
25 | Soydan AS, Tavares IA, Weech PK, Temblay NM and Bennett A (1996) High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue. Eur J Cancer 32A, 1781-1787 DOI |
26 | Ballif BA and Blenis J (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12, 397-408 |
27 | Sharma SV and Settleman J (2007) Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev 21, 3214-3231 DOI |
28 | Fang JY and Richardson BC (2005) The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6, 322-327 DOI |